COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.
The process of bone formation. Histogenesis of bone including ossification.
A clinically and genetically heterogeneous group of hereditary conditions characterized by malformed DENTAL ENAMEL, usually involving DENTAL ENAMEL HYPOPLASIA and/or TOOTH HYPOMINERALIZATION.
Bone lengthening by gradual mechanical distraction. An external fixation device produces the distraction across the bone plate. The technique was originally applied to long bones but in recent years the method has been adapted for use with mandibular implants in maxillofacial surgery.
A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains.
The most common form of fibrillar collagen. It is a major constituent of bone (BONE AND BONES) and SKIN and consists of a heterotrimer of two alpha1(I) and one alpha2(I) chains.
A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).
An autosomal dominant disorder of tooth development characterized by opalescent dentin resulting in discoloration of the teeth. The dentin develops poorly with low mineral content while the pulp canal is obliterated.
A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
A developmental deformity of the occipital bone and upper end of the cervical spine, in which the latter appears to have pushed the floor of the occipital bone upward. (Dorland, 27th ed)
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
Genes whose loss of function or gain of function MUTATION leads to the death of the carrier prior to maturity. They may be essential genes (GENES, ESSENTIAL) required for viability, or genes which cause a block of function of an essential gene at a time when the essential gene function is required for viability.
Extracellular substance of bone tissue consisting of COLLAGEN fibers, ground substance, and inorganic crystalline minerals and salts.
Fractures occurring as a result of disease of a bone or from some undiscoverable cause, and not due to trauma. (Dorland, 27th ed)
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
General disorders of the sclera or white of the eye. They may include anatomic, embryologic, degenerative, or pigmentation defects.
Persistent flexure or contracture of a joint.
A family of peptidyl-prolyl cis-trans isomerases that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-
The molecular unit of collagen fibrils that consist of repeating three-stranded polypeptide units arranged head to tail in parallel bundles. It is a right-handed triple helix composed of 2 polypeptide chains. It is rich in glycine, proline, hydroxyproline, and hydroxylysine.
A heterogeneous group of bone dysplasias, the common character of which is stippling of the epiphyses in infancy. The group includes a severe autosomal recessive form (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC), an autosomal dominant form (Conradi-Hunermann syndrome), and a milder X-linked form. Metabolic defects associated with impaired peroxisomes are present only in the rhizomelic form.
A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.
Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.
The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
Genes that influence the PHENOTYPE only in the homozygous state.
Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.
Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state.
The proteins that are part of the dental enamel matrix.
Breaks in bones.
Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.
An extracellular endopeptidase which excises a block of peptides at the amino terminal, nonhelical region of the procollagen molecule with the formation of collagen. Absence or deficiency of the enzyme causes accumulation of procollagen which results in the inherited connective tissue disorder--dermatosparaxis. EC 3.4.24.14.
Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes.
X-RAY COMPUTERIZED TOMOGRAPHY with resolution in the micrometer range.
The longest and largest bone of the skeleton, it is situated between the hip and the knee.
Developmental bone diseases are a category of skeletal disorders that arise from disturbances in the normal growth and development of bones, including abnormalities in size, shape, structure, or composition, which can lead to various musculoskeletal impairments and deformities.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Diseases of BONES.
The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS.
An infant during the first month after birth.
The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.
The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the canal of Schlemm. (From Cline et al., Dictionary of Visual Science, 4th ed)
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The susceptibility of CAPILLARIES, under conditions of increased stress, to leakage.
An acquired or hereditary condition due to deficiency in the formation of tooth enamel (AMELOGENESIS). It is usually characterized by defective, thin, or malformed DENTAL ENAMEL. Risk factors for enamel hypoplasia include gene mutations, nutritional deficiencies, diseases, and environmental factors.
The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.
A secreted matrix metalloproteinase that is the predominant proteolytic activity in the enamel matrix. The enzyme has a high specificity for dental enamel matrix protein AMELOGENIN.
A set of twelve curved bones which connect to the vertebral column posteriorly, and terminate anteriorly as costal cartilage. Together, they form a protective cage around the internal thoracic organs.
Fenestra or oval opening on the lateral wall of the vestibular labyrinth adjacent to the MIDDLE EAR. It is located above the cochlear round window and normally covered by the base of the STAPES.
The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
An individual in which both alleles at a given locus are identical.
A family of structurally related collagens that form the characteristic collagen fibril bundles seen in CONNECTIVE TISSUE.
An individual having different alleles at one or more loci regarding a specific character.
Experimentation on, or using the organs or tissues from, a human or other mammalian conceptus in the postembryonic period, after the major structures have been outlined. In humans, this corresponds to the period from the third month after fertilization until birth.
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.
A hydroxylated derivative of the amino acid LYSINE that is present in certain collagens.
A major dental enamel-forming protein found in mammals. In humans the protein is encoded by GENES found on both the X CHROMOSOME and the Y CHROMOSOME.
Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
An appreciable lateral deviation in the normally straight vertical line of the spine. (Dorland, 27th ed)
A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
Localized hyperplasia of the horny layer of the epidermis due to pressure or friction. (Dorland, 27th ed)
Basic glycoprotein members of the SERPIN SUPERFAMILY that function as COLLAGEN-specific MOLECULAR CHAPERONES in the ENDOPLASMIC RETICULUM.
An apparently hereditary disorder of dentin formation, marked by a normal appearance of coronal dentin associated with pulpal obliteration, faulty root formation, and a tendency for peripheral lesions without obvious cause. (From Dorland, 27th ed)

Can transvaginal fetal biometry be considered a useful tool for early detection of skeletal dysplasias in high-risk patients? (1/457)

OBJECTIVE: To evaluate the possibility of an early diagnosis of skeletal dysplasias in high-risk patients. METHODS: A total of 149 consecutive, uncomplicated singleton pregnancies at 9-13 weeks' amenorrhea, with certain menstrual history and regular cycles, were investigated with transvaginal ultrasound to establish the relationship between femur length and menstrual age, biparietal diameter and crown-rump length, using a polynomial regression model. A further eight patients with previous skeletal dysplasias in a total of 13 pregnancies were evaluated with serial examinations every 2 weeks from 10-11 weeks. RESULTS: A significant correlation between femur length and crown-rump length and biparietal diameter was found, whereas none was observed between femur length and menstrual age. Of the five cases with skeletal dysplasias, only two (one with recurrent osteogenesis imperfecta and one with recurrent achondrogenesis) were diagnosed in the first trimester. CONCLUSIONS: An early evaluation of fetal morphology in conjunction with the use of biometric charts of femur length against crown-rump length and femur length against biparietal diameter may be crucial for early diagnosis of severe skeletal dysplasias. By contrast, in less severe cases, biometric evaluation appears to be of no value for diagnosis.  (+info)

Basilar impression complicating osteogenesis imperfecta type IV: the clinical and neuroradiological findings in four cases. (2/457)

OBJECTIVES: To describe the clinical and neuroradiological features of basilar impression in patients with osteogenesis imperfecta type IV. METHODS: Four patients with basilar impression were ascertained in a population study of osteogenesis imperfecta. All four had detailed clinical and neuroradiological examination with both CT and MRI of the craniocervical junction and posterior fossa structures. RESULTS: All four showed significant compression of the posterior fossa structures and surgical decompression was performed with relief of symptoms. CONCLUSION: Symptoms of cough headache and trigeminal neuralgia occurring in patients with osteogenesis imperfecta are indications for detailed clinical and neuroradiological investigation to document basilar impression.  (+info)

Joint hypermobility and genetic collagen disorders: are they related? (3/457)

The HDCTs constitute a heterogeneous group of rare genetically determined diseases, the best known of which are Ehlers-Danlos and Marfan syndromes and osteogenesis imperfecta. Hypermobility is a feature common to them all, but it is also a feature that is highly prevalent in the population at large. Symptomatic hypermobile subjects (whose symptoms are attributable to their hypermobility) are said to be suffering from the benign joint hypermobility syndrome, which has many features that overlap with the HDCTs. It is not yet known whether there is a variety of hypermobility (symptomatic or otherwise) that is not part of a connective tissue disorder.  (+info)

Anthropometry of patients with osteogenesis imperfecta. (4/457)

Standing height, sitting height, armspan, subischial leg length, head circumference, and growth hormone-insulin-like growth factor I (IGF-I) axis were determined in 86 patients with osteogenesis imperfecta. The aim of this study was to determine standing height and body proportions and their variability among osteogenesis imperfecta types and collagen defects. Mean standing height was reduced in all groups of patients, to the greatest extent and variability in osteogenesis imperfecta type III/IV and in those with qualitative collagen defects. The mean standing height of patients with osteogenesis imperfecta was lower than that of their unaffected first degree family members. Truncal height of patients with osteogenesis imperfecta was reduced; head size was increased, and this was more pronounced in patients with osteogenesis imperfecta type III/IV and qualitative collagen defects than in patients with osteogenesis imperfecta type I and quantitative collagen defects. Mean concentrations of IGF-I and IGF binding protein 3 (IGFBP-3) were low, but most values were within age specific reference values. The reduction of standing height appears to correlate with osteogenesis imperfecta type and the type of collagen defect. A relatively short trunk is typical and head circumference and body length are disproportionate.  (+info)

Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. (5/457)

Most splice-site mutations lead to a limited array of products, including exon skipping, use of cryptic splice-acceptor or -donor sites, and intron inclusion. At the intron 8 splice-donor site of the COL1A1 gene, we identified a G+1-->A transition that resulted in the production of several splice products from the mutant allele. These included one in which the upstream exon 7 was extended by 96 nt, others in which either intron 8 or introns 7 and 8 were retained, one in which exon 8 was skipped, and one that used a cryptic donor site in exon 8. To determine the mechanism by which exon-7 redefinition might occur, we examined the order of intron removal in the region of the mutation by using intron/exon primer pairs to amplify regions of the precursor nuclear mRNA between exon 5 and exon 10. Removal of introns 5, 6, and 9 was rapid. Removal of intron 8 usually preceded removal of intron 7 in the normal gene, although, in a small proportion of copies, the order was reversed. The proportion of abnormal products suggested that exon 7 redefinition, intron 7 plus intron 8 inclusion, and exon 8 skipping all represented products of the impaired rapid pathway, whereas the intron-8 inclusion product resulted from use of the slow intron 7-first pathway. The very low-abundance cryptic exon 8 donor site product could have arisen from either pathway. These results suggest that there is commitment of the pre-mRNA to the two pathways, independent of the presence of the mutation, and that the order and rate of intron removal are important determinants of the outcome of splice-site mutations and may explain some unusual alterations.  (+info)

Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. (6/457)

Bone marrow stromal cells isolated from a model of osteogenesis imperfecta (oim) mice, were transduced with a retrovirus (BAG) carrying the LacZ and neor genes after passage 21. The transduced cells retained the ability to express alkaline phosphatase activity in vitro when treated with recombinant human bone morphogenetic protein two (rhBMP-2), formed cartilage in vitro in aggregate cultures and formed bone in ceramic cubes after 6 weeks of implantation in nude mice. X-gal staining of ceramic cubes seeded with the transduced cells demonstrated the presence of LacZ-positive cells on the edges of bone and also in the lacunae of the newly formed bone 6 weeks after implantation. After infusion into femurs of oim mice, the transduced cells were detected in the marrow cavity and on the edges of the trabecular bone of the injected and contralateral femurs by X-gal staining and PCR analysis at 4, 10, 20, 30 and 40 days after injection. The LacZ gene was also detected in the lung and liver of the recipient mice at 4 and 10 days after injection but not at later time-periods. The present findings suggest that long-term cultured bone marrow stromal cells from osteogenesis imperfecta (OI) animals have the potential to traffic through the circulatory system, home to bone, form bone and continue to express exogenous genes. These findings open the possibility of using these cells as vehicles to deliver normal genes to bone as an alternative approach for the treatment of some forms of OI and certain other bone acquired and genetic diseases.  (+info)

Proteasomal degradation of unassembled mutant type I collagen pro-alpha1(I) chains. (7/457)

We have previously shown that type I procollagen pro-alpha1(I) chains from an osteogenesis imperfecta patient (OI26) with a frameshift mutation resulting in a truncated C-propeptide, have impaired assembly, and are degraded by an endoplasmic reticulum-associated pathway (Lamande, S. R., Chessler, S. D., Golub, S. B., Byers, P. H., Chan, D., Cole, W. G., Sillence, D. O. and Bateman, J. F. (1995) J. Biol. Chem. 270, 8642-8649). To further explore the degradation of procollagen chains with mutant C-propeptides, mouse Mov13 cells, which produce no endogenous pro-alpha1(I), were stably transfected with a pro-alpha1(I) expression construct containing a frameshift mutation that predicts the synthesis of a protein 85 residues longer than normal. Despite high levels of mutant mRNA in transfected Mov13 cells, only minute amounts of mutant pro-alpha1(I) could be detected indicating that the majority of the mutant pro-alpha1(I) chains synthesized are targeted for rapid intracellular degradation. Degradation was not prevented by brefeldin A, monensin, or NH(4)Cl, agents that interfere with intracellular transport or lysosomal function. However, mutant pro-alpha1(I) chains in both transfected Mov13 cells and OI26 cells were protected from proteolysis by specific proteasome inhibitors. Together these data demonstrate for the first time that procollagen chains containing C-propeptide mutations that impair assembly are degraded by the cytoplasmic proteasome complex, and that the previously identified endoplasmic reticulum-associated degradation of mutant pro-alpha1(I) in OI26 is mediated by proteasomes.  (+info)

Two sibs with an unusual pattern of skeletal malformations resembling osteogenesis imperfecta: a new type of skeletal dysplasia? (8/457)

We report a 6 year old boy with multiple fractures owing to bilateral, peculiar, wave-like defects of the tibial corticalis with alternative hyperostosis and thinning. Furthermore, he had Wormian bones of the skull, dentinogenesis imperfecta, and a distinct facial phenotype with hypertelorism and periorbital fullness. Collagen studies showed normal results. His sister, aged 2 years, showed the same facial phenotype and dental abnormalities as well as Wormian bones, but no radiographical abnormalities of the tubular bones so far. The mother also had dentine abnormalities but no skeletal abnormalities on x ray. This entity is probably the same as that described in a sporadic case by Suarez and Stickler in 1974. In spite of the considerable overlap with osteogenesis imperfecta (bone fragility, Wormian bones, and dentinogenesis imperfecta), we believe this disorder to be a different entity, in particular because of the unique cortical defects, missing osteopenia, and normal results of collagen studies.  (+info)

Osteogenesis Imperfecta (OI), also known as brittle bone disease, is a group of genetic disorders that mainly affect the bones. It is characterized by bones that break easily, often from little or no apparent cause. This happens because the body produces an insufficient amount of collagen or poor quality collagen, which are crucial for the formation of healthy bones.

The severity of OI can vary greatly, even within the same family. Some people with OI have only a few fractures in their lifetime while others may have hundreds. Other symptoms can include blue or gray sclera (the white part of the eye), hearing loss, short stature, curved or bowed bones, loose joints, and a triangular face shape.

There are several types of OI, each caused by different genetic mutations. Most types of OI are inherited in an autosomal dominant pattern, meaning only one copy of the altered gene is needed to cause the condition. However, some types are inherited in an autosomal recessive pattern, which means that two copies of the altered gene must be present for the condition to occur.

There is no cure for OI, but treatment can help manage symptoms and prevent complications. Treatment may include medication to strengthen bones, physical therapy, bracing, and surgery.

Osteogenesis is the process of bone formation or development. It involves the differentiation and maturation of osteoblasts, which are bone-forming cells that synthesize and deposit the organic matrix of bone tissue, composed mainly of type I collagen. This organic matrix later mineralizes to form the inorganic crystalline component of bone, primarily hydroxyapatite.

There are two primary types of osteogenesis: intramembranous and endochondral. Intramembranous osteogenesis occurs directly within connective tissue, where mesenchymal stem cells differentiate into osteoblasts and form bone tissue without an intervening cartilage template. This process is responsible for the formation of flat bones like the skull and clavicles.

Endochondral osteogenesis, on the other hand, involves the initial development of a cartilaginous model or template, which is later replaced by bone tissue. This process forms long bones, such as those in the limbs, and occurs through several stages involving chondrocyte proliferation, hypertrophy, and calcification, followed by invasion of blood vessels and osteoblasts to replace the cartilage with bone tissue.

Abnormalities in osteogenesis can lead to various skeletal disorders and diseases, such as osteogenesis imperfecta (brittle bone disease), achondroplasia (a form of dwarfism), and cleidocranial dysplasia (a disorder affecting skull and collarbone development).

Amelogenesis Imperfecta is a group of inherited dental disorders that affect the structure and appearance of tooth enamel. It is caused by mutations in various genes involved in the development and formation of enamel. The condition can be characterized by small, discolored, and poorly formed teeth that are prone to rapid wear, decay, and sensitivity. There are several types of Amelogenesis Imperfecta, which vary in their severity and the specific symptoms they present. Treatment typically focuses on managing the symptoms and improving the appearance and function of the teeth through restorative dental procedures.

Osteogenesis, distraction refers to a surgical procedure and controlled rehabilitation process used in orthopedic surgery, oral and maxillofacial surgery, and neurosurgery to lengthen bones or correct bone deformities. The term "osteogenesis" means bone formation, while "distraction" refers to the gradual separation of bone segments.

In this procedure, a surgeon first cuts the bone (osteotomy) and then applies an external or internal distraction device that slowly moves apart the cut ends of the bone. Over time, new bone forms in the gap between the separated bone segments through a process called distraction osteogenesis. This results in increased bone length or correction of deformities.

Distraction osteogenesis is often used to treat various conditions such as limb length discrepancies, craniofacial deformities, and spinal deformities. The procedure requires careful planning, precise surgical technique, and close postoperative management to ensure optimal outcomes.

Procollagen is the precursor protein of collagen, which is a major structural protein in the extracellular matrix of various connective tissues, such as tendons, ligaments, skin, and bones. Procollagen is synthesized inside the cell (in the rough endoplasmic reticulum) and then processed by enzymes to remove specific segments, resulting in the formation of tropocollagen, which are the basic units of collagen fibrils.

Procollagen consists of three polypeptide chains (two alpha-1 and one alpha-2 chain), each containing a central triple-helical domain flanked by non-helical regions at both ends. These non-helical regions, called propeptides, are cleaved off during the processing of procollagen to tropocollagen, allowing the individual collagen molecules to align and form fibrils through covalent cross-linking.

Abnormalities in procollagen synthesis or processing can lead to various connective tissue disorders, such as osteogenesis imperfecta (brittle bone disease) and Ehlers-Danlos syndrome (a group of disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility).

Collagen Type I is the most abundant form of collagen in the human body, found in various connective tissues such as tendons, ligaments, skin, and bones. It is a structural protein that provides strength and integrity to these tissues. Collagen Type I is composed of three alpha chains, two alpha-1(I) chains, and one alpha-2(I) chain, arranged in a triple helix structure. This type of collagen is often used in medical research and clinical applications, such as tissue engineering and regenerative medicine, due to its excellent mechanical properties and biocompatibility.

Collagen is the most abundant protein in the human body, and it is a major component of connective tissues such as tendons, ligaments, skin, and bones. Collagen provides structure and strength to these tissues and helps them to withstand stretching and tension. It is made up of long chains of amino acids, primarily glycine, proline, and hydroxyproline, which are arranged in a triple helix structure. There are at least 16 different types of collagen found in the body, each with slightly different structures and functions. Collagen is important for maintaining the integrity and health of tissues throughout the body, and it has been studied for its potential therapeutic uses in various medical conditions.

Dentinogenesis Imperfecta (DI) is a genetic disorder that affects the development and formation of dentin, which is the hard tissue beneath the enamel of teeth. This condition results in teeth that are discolored, translucent, and sensitive to temperature changes. The teeth may also wear down easily and be prone to fractures.

There are two main types of Dentinogenesis Imperfecta: type I and type II. Type I is associated with a genetic disorder called osteogenesis imperfecta (OI), which affects the development of bones as well as teeth. Type II, on the other hand, is not associated with OI and only affects the teeth.

The inheritance pattern for Dentinogenesis Imperfecta is autosomal dominant, meaning that a child has a 50% chance of inheriting the condition if one parent has it. However, some cases may be due to new mutations in the gene and not inherited from a parent. Treatment for DI typically involves dental restorations such as crowns or veneers to improve the appearance and function of the teeth.

Glycine is a simple amino acid that plays a crucial role in the body. According to the medical definition, glycine is an essential component for the synthesis of proteins, peptides, and other biologically important compounds. It is also involved in various metabolic processes, such as the production of creatine, which supports muscle function, and the regulation of neurotransmitters, affecting nerve impulse transmission and brain function. Glycine can be found as a free form in the body and is also present in many dietary proteins.

Platybasia is a medical term that refers to a condition where the base of the skull is flattened or broadened, resulting in an abnormal increase in the angle between the clivus (a part of the sphenoid bone) and the posterior aspect of the upper surface of the palatine bone. This condition can be congenital or acquired and is often associated with other skeletal abnormalities. In some cases, platybasia may lead to neurological symptoms such as headaches, neck pain, or even brainstem compression.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

"Bone" is the hard, dense connective tissue that makes up the skeleton of vertebrate animals. It provides support and protection for the body's internal organs, and serves as a attachment site for muscles, tendons, and ligaments. Bone is composed of cells called osteoblasts and osteoclasts, which are responsible for bone formation and resorption, respectively, and an extracellular matrix made up of collagen fibers and mineral crystals.

Bones can be classified into two main types: compact bone and spongy bone. Compact bone is dense and hard, and makes up the outer layer of all bones and the shafts of long bones. Spongy bone is less dense and contains large spaces, and makes up the ends of long bones and the interior of flat and irregular bones.

The human body has 206 bones in total. They can be further classified into five categories based on their shape: long bones, short bones, flat bones, irregular bones, and sesamoid bones.

A lethal gene is a type of gene that causes the death of an organism or prevents it from surviving to maturity. This can occur when the gene contains a mutation that disrupts the function of a protein essential for the organism's survival. In some cases, the presence of two copies of a lethal gene (one inherited from each parent) can result in a condition that is incompatible with life, and the organism will not survive beyond embryonic development or shortly after birth.

Lethal genes can also contribute to genetic disorders, where the disruption of protein function caused by the mutation leads to progressive degeneration and ultimately death. In some cases, lethal genes may only cause harm when expressed in certain tissues or at specific stages of development, leading to a range of phenotypes from embryonic lethality to adult-onset disorders.

It's important to note that the term "lethal" is relative and can depend on various factors such as genetic background, environmental conditions, and the presence of modifier genes. Additionally, some lethal genes may be targeted for gene editing or other therapeutic interventions to prevent their harmful effects.

Bone matrix refers to the non-cellular component of bone that provides structural support and functions as a reservoir for minerals, such as calcium and phosphate. It is made up of organic and inorganic components. The organic component consists mainly of type I collagen fibers, which provide flexibility and tensile strength to the bone. The inorganic component is primarily composed of hydroxyapatite crystals, which give bone its hardness and compressive strength. Bone matrix also contains other proteins, growth factors, and signaling molecules that regulate bone formation, remodeling, and repair.

Spontaneous fractures are bone breaks that occur without any identifiable trauma or injury. They are typically caused by underlying medical conditions that weaken the bones, making them more susceptible to breaking under normal stress or weight. The most common cause of spontaneous fractures is osteoporosis, a condition characterized by weak and brittle bones. Other potential causes include various bone diseases, certain cancers, long-term use of corticosteroids, and genetic disorders affecting bone strength.

It's important to note that while the term "spontaneous" implies that the fracture occurred without any apparent cause, it is usually the result of an underlying medical condition. Therefore, if you experience a spontaneous fracture, seeking medical attention is crucial to diagnose and manage the underlying cause to prevent future fractures and related complications.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

Scleral diseases refer to conditions that affect the sclera, which is the tough, white outer coating of the eye. The sclera helps to maintain the shape of the eye and provides protection for the internal structures. Scleral diseases can cause inflammation, degeneration, or thinning of the sclera, leading to potential vision loss or other complications. Some examples of scleral diseases include:

1. Scleritis: an inflammatory condition that causes pain, redness, and sensitivity in the affected area of the sclera. It can be associated with autoimmune disorders, infections, or trauma.
2. Episcleritis: a less severe form of inflammation that affects only the episclera, a thin layer of tissue overlying the sclera. Symptoms include redness and mild discomfort but typically no pain.
3. Pinguecula: a yellowish, raised deposit of protein and fat that forms on the conjunctiva, the clear membrane covering the sclera. While not a disease itself, a pinguecula can cause irritation or discomfort and may progress to a more severe condition called a pterygium.
4. Pterygium: a fleshy growth that extends from the conjunctiva onto the cornea, potentially obstructing vision. It is often associated with prolonged sun exposure and can be removed surgically if it becomes problematic.
5. Scleral thinning or melting: a rare but serious condition where the sclera degenerates or liquefies, leading to potential perforation of the eye. This can occur due to autoimmune disorders, infections, or as a complication of certain surgical procedures.
6. Ocular histoplasmosis syndrome (OHS): a condition caused by the Histoplasma capsulatum fungus, which can lead to scarring and vision loss if it involves the macula, the central part of the retina responsible for sharp, detailed vision.

It is essential to consult an ophthalmologist or eye care professional if you experience any symptoms related to scleral diseases to receive proper diagnosis and treatment.

Arthrogryposis is a medical term that describes a condition characterized by the presence of multiple joint contractures at birth. A contracture occurs when the range of motion in a joint is limited, making it difficult or impossible to move the joint through its full range of motion. In arthrogryposis, these contractures are present in two or more areas of the body.

The term "arthrogryposis" comes from two Greek words: "arthro," meaning joint, and "gyros," meaning curved or bent. Therefore, arthrogryposis literally means "curving of the joints."

There are many different types of arthrogryposis, each with its own specific set of symptoms and causes. However, in general, arthrogryposis is caused by decreased fetal movement during pregnancy, which can be due to a variety of factors such as genetic mutations, nervous system abnormalities, or environmental factors that restrict fetal movement.

Treatment for arthrogryposis typically involves a combination of physical therapy, bracing, and surgery to help improve joint mobility and function. The prognosis for individuals with arthrogryposis varies depending on the severity and type of contractures present, as well as the underlying cause of the condition.

Cyclophilins are a family of proteins that have peptidyl-prolyl isomerase activity, which means they help with the folding and functioning of other proteins in cells. They were first identified as binding proteins for the immunosuppressive drug cyclosporine A, hence their name.

Cyclophilins are found in various organisms, including humans, and play important roles in many cellular processes such as signal transduction, protein trafficking, and gene expression. In addition to their role in normal cell function, cyclophilins have also been implicated in several diseases, including viral infections, cancer, and neurodegenerative disorders.

In medicine, the most well-known use of cyclophilins is as a target for immunosuppressive drugs used in organ transplantation. Cyclosporine A and its derivatives work by binding to cyclophilins, which inhibits their activity and subsequently suppresses the immune response.

Tropocollagen is the fundamental unit of collagen, a protein that provides strength and structure to various tissues in the body. It is composed of three polypeptide chains coiled together in a triple helix structure. These chains are rich in the amino acids proline and hydroxyproline, which contribute to the stability of the helical structure. Tropocollagen molecules can further assemble into larger fibrils and fibers, providing tensile strength to tissues such as tendons, ligaments, and skin.

Chondrodysplasia punctata is a group of genetic disorders that affect the development of bones and cartilage. The condition is characterized by stippled calcifications, or spots of calcium deposits, in the cartilage that can be seen on X-rays. These spots are typically found at the ends of long bones, in the sternum, and in the pelvis.

The symptoms of chondrodysplasia punctata can vary widely depending on the specific type of the disorder. Some people with the condition may have short stature, bowed legs, and other skeletal abnormalities, while others may have only mild symptoms or no symptoms at all. The condition can also be associated with developmental delays, intellectual disability, and other health problems.

There are several different types of chondrodysplasia punctata, each caused by a different genetic mutation. Some forms of the disorder are inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition. Other forms of chondrodysplasia punctata are inherited in an X-linked dominant manner, meaning that a single copy of the mutated gene (on the X chromosome) is enough to cause the disorder in females. Males, who have only one X chromosome, will typically be more severely affected by X-linked dominant disorders.

There is no cure for chondrodysplasia punctata, and treatment is focused on managing the symptoms of the condition. This may include physical therapy, bracing or surgery to correct skeletal abnormalities, and medications to manage pain or other health problems.

Ehlers-Danlos syndrome (EDS) is a group of inherited disorders that affect connective tissues, which are the proteins and chemicals in the body that provide structure and support for skin, bones, blood vessels, and other organs. People with EDS have stretching (elastic) skin and joints that are too loose (hypermobile). There are several types of EDS, each with its own set of symptoms and level of severity. Some of the more common types include:

* Classical EDS: This type is characterized by skin that can be stretched far beyond normal and bruises easily. Affected individuals may also have joints that dislocate easily.
* Hypermobile EDS: This type is marked by joint hypermobility, which can lead to frequent dislocations and subluxations (partial dislocations). Some people with this type of EDS also have Marfan syndrome-like features, such as long fingers and a curved spine.
* Vascular EDS: This type is caused by changes in the COL3A1 gene and is characterized by thin, fragile skin that tears or bruises easily. People with vascular EDS are at risk of serious complications, such as arterial rupture and organ perforation.
* Kyphoscoliosis EDS: This type is marked by severe kyphoscoliosis (a forward curvature of the spine) and joint laxity. Affected individuals may also have fragile skin that tears or bruises easily.

EDS is typically inherited in an autosomal dominant manner, meaning that a person only needs to inherit one copy of the altered gene from either parent to develop the condition. However, some types of EDS are inherited in an autosomal recessive manner, which means that a person must inherit two copies of the altered gene (one from each parent) to develop the condition.

There is no cure for EDS, and treatment is focused on managing symptoms and preventing complications. This may include physical therapy to strengthen muscles and improve joint stability, bracing to support joints, and surgery to repair damaged tissues or organs.

Diphosphonates are a class of medications that are used to treat bone diseases, such as osteoporosis and Paget's disease. They work by binding to the surface of bones and inhibiting the activity of bone-resorbing cells called osteoclasts. This helps to slow down the breakdown and loss of bone tissue, which can help to reduce the risk of fractures.

Diphosphonates are typically taken orally in the form of tablets, but some forms may be given by injection. Commonly prescribed diphosphonates include alendronate (Fosamax), risedronate (Actonel), and ibandronate (Boniva). Side effects of diphosphonates can include gastrointestinal symptoms such as nausea, heartburn, and abdominal pain. In rare cases, they may also cause esophageal ulcers or osteonecrosis of the jaw.

It is important to follow the instructions for taking diphosphonates carefully, as they must be taken on an empty stomach with a full glass of water and the patient must remain upright for at least 30 minutes after taking the medication to reduce the risk of esophageal irritation. Regular monitoring of bone density and kidney function is also recommended while taking these medications.

Physiologic calcification is the normal deposit of calcium salts in body tissues and organs. It is a natural process that occurs as part of the growth and development of the human body, as well as during the repair and remodeling of tissues.

Calcium is an essential mineral that plays a critical role in many bodily functions, including bone formation, muscle contraction, nerve impulse transmission, and blood clotting. In order to maintain proper levels of calcium in the body, excess calcium that is not needed for these functions may be deposited in various tissues as a normal part of the aging process.

Physiologic calcification typically occurs in areas such as the walls of blood vessels, the lungs, and the heart valves. While these calcifications are generally harmless, they can sometimes lead to complications, particularly if they occur in large amounts or in sensitive areas. For example, calcification of the coronary arteries can increase the risk of heart disease, while calcification of the lung tissue can cause respiratory symptoms.

It is important to note that pathologic calcification, on the other hand, refers to the abnormal deposit of calcium salts in tissues and organs, which can be caused by various medical conditions such as chronic kidney disease, hyperparathyroidism, and certain infections. Pathologic calcification is not a normal process and can lead to serious health complications if left untreated.

In medical terms, the skin is the largest organ of the human body. It consists of two main layers: the epidermis (outer layer) and dermis (inner layer), as well as accessory structures like hair follicles, sweat glands, and oil glands. The skin plays a crucial role in protecting us from external factors such as bacteria, viruses, and environmental hazards, while also regulating body temperature and enabling the sense of touch.

Recessive genes refer to the alleles (versions of a gene) that will only be expressed when an individual has two copies of that particular allele, one inherited from each parent. If an individual inherits one recessive allele and one dominant allele for a particular gene, the dominant allele will be expressed and the recessive allele will have no effect on the individual's phenotype (observable traits).

Recessive genes can still play a role in determining an individual's genetic makeup and can be passed down through generations even if they are not expressed. If two carriers of a recessive gene have children, there is a 25% chance that their offspring will inherit two copies of the recessive allele and exhibit the associated recessive trait.

Examples of genetic disorders caused by recessive genes include cystic fibrosis, sickle cell anemia, and albinism.

Osteoblasts are specialized bone-forming cells that are derived from mesenchymal stem cells. They play a crucial role in the process of bone formation and remodeling. Osteoblasts synthesize, secrete, and mineralize the organic matrix of bones, which is mainly composed of type I collagen.

These cells have receptors for various hormones and growth factors that regulate their activity, such as parathyroid hormone, vitamin D, and transforming growth factor-beta. When osteoblasts are not actively producing bone matrix, they can become trapped within the matrix they produce, where they differentiate into osteocytes, which are mature bone cells that play a role in maintaining bone structure and responding to mechanical stress.

Abnormalities in osteoblast function can lead to various bone diseases, such as osteoporosis, osteogenesis imperfecta, and Paget's disease of bone.

Dominant genes refer to the alleles (versions of a gene) that are fully expressed in an individual's phenotype, even if only one copy of the gene is present. In dominant inheritance patterns, an individual needs only to receive one dominant allele from either parent to express the associated trait. This is in contrast to recessive genes, where both copies of the gene must be the recessive allele for the trait to be expressed. Dominant genes are represented by uppercase letters (e.g., 'A') and recessive genes by lowercase letters (e.g., 'a'). If an individual inherits one dominant allele (A) from either parent, they will express the dominant trait (A).

Dental enamel is the hard, outermost layer of a tooth that protects the dentin and pulp inside. It is primarily made up of minerals, mainly hydroxyapatite, and contains very little organic material. However, during the formation of dental enamel, proteins are synthesized and secreted by ameloblast cells, which help in the development and mineralization of the enamel. These proteins play a crucial role in the proper formation and structure of the enamel.

Some of the main dental enamel proteins include:

1. Amelogenin: This is the most abundant protein found in developing enamel, accounting for about 90% of the organic matrix. Amelogenin helps regulate the growth and organization of hydroxyapatite crystals during mineralization. It also plays a role in determining the final hardness and structure of the enamel.

2. Enamelin: This protein is the second most abundant protein in developing enamel, accounting for about 5-10% of the organic matrix. Enamelin is involved in the elongation and thickening of hydroxyapatite crystals during mineralization. It also helps maintain the stability of the enamel structure.

3. Ameloblastin: This protein is produced by ameloblast cells and is essential for proper enamel formation. Ameloblastin plays a role in regulating crystal growth, promoting adhesion between crystals, and maintaining the structural integrity of the enamel.

4. Tuftelin: This protein is found in both dentin and enamel but is more abundant in enamel. Tuftelin is involved in the initiation of mineralization and helps regulate crystal growth during this process.

5. Dentin sialophosphoprotein (DSPP): Although primarily associated with dentin formation, DSPP is also found in developing enamel. It plays a role in regulating crystal growth and promoting adhesion between crystals during mineralization.

After the formation of dental enamel is complete, these proteins are largely degraded and removed, leaving behind the highly mineralized and hard tissue that characterizes mature enamel. However, traces of these proteins may still be present in the enamel and could potentially play a role in its structure and properties.

A bone fracture is a medical condition in which there is a partial or complete break in the continuity of a bone due to external or internal forces. Fractures can occur in any bone in the body and can vary in severity from a small crack to a shattered bone. The symptoms of a bone fracture typically include pain, swelling, bruising, deformity, and difficulty moving the affected limb. Treatment for a bone fracture may involve immobilization with a cast or splint, surgery to realign and stabilize the bone, or medication to manage pain and prevent infection. The specific treatment approach will depend on the location, type, and severity of the fracture.

Fibroblasts are specialized cells that play a critical role in the body's immune response and wound healing process. They are responsible for producing and maintaining the extracellular matrix (ECM), which is the non-cellular component present within all tissues and organs, providing structural support and biochemical signals for surrounding cells.

Fibroblasts produce various ECM proteins such as collagens, elastin, fibronectin, and laminins, forming a complex network of fibers that give tissues their strength and flexibility. They also help in the regulation of tissue homeostasis by controlling the turnover of ECM components through the process of remodeling.

In response to injury or infection, fibroblasts become activated and start to proliferate rapidly, migrating towards the site of damage. Here, they participate in the inflammatory response, releasing cytokines and chemokines that attract immune cells to the area. Additionally, they deposit new ECM components to help repair the damaged tissue and restore its functionality.

Dysregulation of fibroblast activity has been implicated in several pathological conditions, including fibrosis (excessive scarring), cancer (where they can contribute to tumor growth and progression), and autoimmune diseases (such as rheumatoid arthritis).

Procollagen N-Endopeptidase, also known as ADAMTS2 (A Disintegrin And Metalloproteinase with Thrombospondin type 1 motif, member 2), is an enzyme involved in the processing and maturation of procollagens. Specifically, it cleaves off the N-terminal extension peptides from procollagen types I, II, and III, allowing for the formation of stable collagen fibrils. Mutations in the ADAMTS2 gene can lead to various connective tissue disorders, such as Ehlers-Danlos syndrome and dermatosparaxis type of cutis laxa.

Cyanogen bromide is a solid compound with the chemical formula (CN)Br. It is a highly reactive and toxic substance that is used in research and industrial settings for various purposes, such as the production of certain types of resins and gels. Cyanogen bromide is an alkyl halide, which means it contains a bromine atom bonded to a carbon atom that is also bonded to a cyano group (a nitrogen atom bonded to a carbon atom with a triple bond).

Cyanogen bromide is classified as a class B poison, which means it can cause harm or death if swallowed, inhaled, or absorbed through the skin. It can cause irritation and burns to the eyes, skin, and respiratory tract, and prolonged exposure can lead to more serious health effects, such as damage to the nervous system and kidneys. Therefore, it is important to handle cyanogen bromide with care and to use appropriate safety precautions when working with it.

X-ray microtomography, often referred to as micro-CT, is a non-destructive imaging technique used to visualize and analyze the internal structure of objects with high spatial resolution. It is based on the principles of computed tomography (CT), where multiple X-ray images are acquired at different angles and then reconstructed into cross-sectional slices using specialized software. These slices can be further processed to create 3D visualizations, allowing researchers and clinicians to examine the internal structure and composition of samples in great detail. Micro-CT is widely used in materials science, biology, medicine, and engineering for various applications such as material characterization, bone analysis, and defect inspection.

The femur is the medical term for the thigh bone, which is the longest and strongest bone in the human body. It connects the hip bone to the knee joint and plays a crucial role in supporting the weight of the body and allowing movement during activities such as walking, running, and jumping. The femur is composed of a rounded head, a long shaft, and two condyles at the lower end that articulate with the tibia and patella to form the knee joint.

Developmental bone diseases are a group of medical conditions that affect the growth and development of bones. These diseases are present at birth or develop during childhood and adolescence, when bones are growing rapidly. They can result from genetic mutations, hormonal imbalances, or environmental factors such as poor nutrition.

Some examples of developmental bone diseases include:

1. Osteogenesis imperfecta (OI): Also known as brittle bone disease, OI is a genetic disorder that affects the body's production of collagen, a protein necessary for healthy bones. People with OI have fragile bones that break easily and may also experience other symptoms such as blue sclerae (whites of the eyes), hearing loss, and joint laxity.
2. Achondroplasia: This is the most common form of dwarfism, caused by a genetic mutation that affects bone growth. People with achondroplasia have short limbs and a large head relative to their body size.
3. Rickets: A condition caused by vitamin D deficiency or an inability to absorb or use vitamin D properly. This leads to weak, soft bones that can bow or bend easily, particularly in children.
4. Fibrous dysplasia: A rare bone disorder where normal bone is replaced with fibrous tissue, leading to weakened bones and deformities.
5. Scoliosis: An abnormal curvature of the spine that can develop during childhood or adolescence. While not strictly a developmental bone disease, scoliosis can be caused by various underlying conditions such as cerebral palsy, muscular dystrophy, or spina bifida.

Treatment for developmental bone diseases varies depending on the specific condition and its severity. Treatment may include medication, physical therapy, bracing, or surgery to correct deformities and improve function. Regular follow-up with a healthcare provider is essential to monitor growth, manage symptoms, and prevent complications.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Bone diseases is a broad term that refers to various medical conditions that affect the bones. These conditions can be categorized into several groups, including:

1. Developmental and congenital bone diseases: These are conditions that affect bone growth and development before or at birth. Examples include osteogenesis imperfecta (brittle bone disease), achondroplasia (dwarfism), and cleidocranial dysostosis.
2. Metabolic bone diseases: These are conditions that affect the body's ability to maintain healthy bones. They are often caused by hormonal imbalances, vitamin deficiencies, or problems with mineral metabolism. Examples include osteoporosis, osteomalacia, and Paget's disease of bone.
3. Inflammatory bone diseases: These are conditions that cause inflammation in the bones. They can be caused by infections, autoimmune disorders, or other medical conditions. Examples include osteomyelitis, rheumatoid arthritis, and ankylosing spondylitis.
4. Degenerative bone diseases: These are conditions that cause the bones to break down over time. They can be caused by aging, injury, or disease. Examples include osteoarthritis, avascular necrosis, and diffuse idiopathic skeletal hyperostosis (DISH).
5. Tumors and cancers of the bone: These are conditions that involve abnormal growths in the bones. They can be benign or malignant. Examples include osteosarcoma, chondrosarcoma, and Ewing sarcoma.
6. Fractures and injuries: While not strictly a "disease," fractures and injuries are common conditions that affect the bones. They can result from trauma, overuse, or weakened bones. Examples include stress fractures, compound fractures, and dislocations.

Overall, bone diseases can cause a wide range of symptoms, including pain, stiffness, deformity, and decreased mobility. Treatment for these conditions varies depending on the specific diagnosis but may include medication, surgery, physical therapy, or lifestyle changes.

Bone density refers to the amount of bone mineral content (usually measured in grams) in a given volume of bone (usually measured in cubic centimeters). It is often used as an indicator of bone strength and fracture risk. Bone density is typically measured using dual-energy X-ray absorptiometry (DXA) scans, which provide a T-score that compares the patient's bone density to that of a young adult reference population. A T-score of -1 or above is considered normal, while a T-score between -1 and -2.5 indicates osteopenia (low bone mass), and a T-score below -2.5 indicates osteoporosis (porous bones). Regular exercise, adequate calcium and vitamin D intake, and medication (if necessary) can help maintain or improve bone density and prevent fractures.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

The skull is the bony structure that encloses and protects the brain, the eyes, and the ears. It is composed of two main parts: the cranium, which contains the brain, and the facial bones. The cranium is made up of several fused flat bones, while the facial bones include the upper jaw (maxilla), lower jaw (mandible), cheekbones, nose bones, and eye sockets (orbits).

The skull also provides attachment points for various muscles that control chewing, moving the head, and facial expressions. Additionally, it contains openings for blood vessels, nerves, and the spinal cord to pass through. The skull's primary function is to protect the delicate and vital structures within it from injury and trauma.

The sclera is the tough, white, fibrous outer coating of the eye in humans and other vertebrates, covering about five sixths of the eyeball's surface. It provides protection for the delicate inner structures of the eye and maintains its shape. The sclera is composed mainly of collagen and elastic fiber, making it strong and resilient. Its name comes from the Greek word "skleros," which means hard.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Capillary fragility refers to the susceptibility of the small blood vessels, or capillaries, to damage and rupture. Capillaries are tiny, hair-like vessels that form a network between arteries and veins, allowing oxygenated blood to flow from the heart to the rest of the body, and deoxygenated blood to return to the heart.

Capillary fragility can be caused by various factors, including genetics, aging, certain medical conditions (such as hypertension, diabetes, and vitamin C deficiency), and medications (such as corticosteroids). When capillaries become fragile, they may rupture easily, leading to bleeding under the skin, bruising, or other symptoms.

In clinical settings, capillary fragility is often assessed through a test called the "tourniquet test," which measures the time it takes for bruising to appear after applying pressure to a small area of the skin. A longer-than-normal time may indicate capillary fragility. However, this test has limitations and is not always reliable in diagnosing capillary fragility.

Dental enamel hypoplasia is a condition characterized by the deficiency or reduction in the thickness of the tooth's enamel surface. This results in the enamel being thin, weak, and prone to wear, fractures, and dental cavities. The appearance of teeth with enamel hypoplasia may be yellowish, brownish, or creamy white, and they can have pits, grooves, or bands of varying widths and shapes.

Enamel hypoplasia can occur due to various factors, including genetics, premature birth, low birth weight, malnutrition, infections during childhood (such as measles or chickenpox), trauma, exposure to environmental toxins, and certain medical conditions that affect enamel formation.

The condition is usually diagnosed through a dental examination, where the dentist can observe and assess the appearance and structure of the teeth. Treatment options depend on the severity of the hypoplasia and may include fluoride treatments, sealants, fillings, crowns, or extractions in severe cases. Preventive measures such as maintaining good oral hygiene, a balanced diet, and regular dental check-ups can help reduce the risk of developing enamel hypoplasia.

The tibia, also known as the shin bone, is the larger of the two bones in the lower leg and part of the knee joint. It supports most of the body's weight and is a major insertion point for muscles that flex the foot and bend the leg. The tibia articulates with the femur at the knee joint and with the fibula and talus bone at the ankle joint. Injuries to the tibia, such as fractures, are common in sports and other activities that put stress on the lower leg.

Matrix metalloproteinase-20 (MMP-20) is a type of enzyme that belongs to the matrix metalloproteinase (MMP) family. MMPs are involved in the breakdown and remodeling of extracellular matrix components, such as collagen and elastin.

MMP-20, also known as Enamelysin, is primarily expressed in developing teeth and plays a crucial role in tooth development and mineralization. It is responsible for the degradation of enamel proteins during tooth formation, helping to shape and harden the enamel matrix. MMP-20 is secreted by ameloblasts, which are the cells that produce enamel.

Defects in MMP-20 have been associated with dental disorders such as Amelogenesis imperfecta, a group of genetic conditions characterized by abnormalities in tooth enamel formation and structure.

In medical terms, ribs are the long, curved bones that make up the ribcage in the human body. They articulate with the thoracic vertebrae posteriorly and connect to the sternum anteriorly via costal cartilages. There are 12 pairs of ribs in total, and they play a crucial role in protecting the lungs and heart, allowing room for expansion and contraction during breathing. Ribs also provide attachment points for various muscles involved in respiration and posture.

The oval window ( fenestra vestibuli ) is a small opening in the inner ear, specifically in the bony labyrinth of the temporal bone. It connects the middle ear to the vestibular system of the inner ear, more precisely to the vestibule. The oval window is covered by the base of the stapes, one of the three smallest bones in the human body, also known as the stirrup. This arrangement allows for the transmission of vibratory energy from the tympanic membrane (eardrum) to the inner ear, which is essential for hearing.

Bone development, also known as ossification, is the process by which bone tissue is formed and grows. This complex process involves several different types of cells, including osteoblasts, which produce new bone matrix, and osteoclasts, which break down and resorb existing bone tissue.

There are two main types of bone development: intramembranous and endochondral ossification. Intramembranous ossification occurs when bone tissue forms directly from connective tissue, while endochondral ossification involves the formation of a cartilage model that is later replaced by bone.

During fetal development, most bones develop through endochondral ossification, starting as a cartilage template that is gradually replaced by bone tissue. However, some bones, such as those in the skull and clavicles, develop through intramembranous ossification.

Bone development continues after birth, with new bone tissue being laid down and existing tissue being remodeled throughout life. This ongoing process helps to maintain the strength and integrity of the skeleton, allowing it to adapt to changing mechanical forces and repair any damage that may occur.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

A homozygote is an individual who has inherited the same allele (version of a gene) from both parents and therefore possesses two identical copies of that allele at a specific genetic locus. This can result in either having two dominant alleles (homozygous dominant) or two recessive alleles (homozygous recessive). In contrast, a heterozygote has inherited different alleles from each parent for a particular gene.

The term "homozygote" is used in genetics to describe the genetic makeup of an individual at a specific locus on their chromosomes. Homozygosity can play a significant role in determining an individual's phenotype (observable traits), as having two identical alleles can strengthen the expression of certain characteristics compared to having just one dominant and one recessive allele.

Fibrillar collagens are a type of collagen that form rope-like fibrils in the extracellular matrix of connective tissues. They are composed of three polypeptide chains, called alpha chains, which are coiled together in a triple helix structure. The most common types of fibrillar collagens are Type I, II, III, V, and XI. These collagens provide strength and support to tissues such as tendons, ligaments, skin, and bones. They also play important roles in the regulation of cell behavior and tissue development. Mutations in genes encoding fibrillar collagens can lead to a variety of connective tissue disorders, including osteogenesis imperfecta, Ehlers-Danlos syndrome, and Marfan syndrome.

A heterozygote is an individual who has inherited two different alleles (versions) of a particular gene, one from each parent. This means that the individual's genotype for that gene contains both a dominant and a recessive allele. The dominant allele will be expressed phenotypically (outwardly visible), while the recessive allele may or may not have any effect on the individual's observable traits, depending on the specific gene and its function. Heterozygotes are often represented as 'Aa', where 'A' is the dominant allele and 'a' is the recessive allele.

Fetal research refers to the scientific study of fetal tissues, organs, and fluids for the purpose of advancing our understanding of human development, health, and disease. This may involve the use of fetal tissue from elective abortions, spontaneous miscarriages, or therapeutic abortions performed for medical reasons. The research can provide valuable insights into various aspects of biology and medicine, including genetic disorders, birth defects, infectious diseases, and developmental abnormalities. It has the potential to lead to the development of new treatments and therapies for a wide range of medical conditions. However, fetal research is a highly controversial topic due to ethical considerations and restrictions may vary depending on the jurisdiction.

Bone density conservation agents, also known as anti-resorptive agents or bone-sparing drugs, are a class of medications that help to prevent the loss of bone mass and reduce the risk of fractures. They work by inhibiting the activity of osteoclasts, the cells responsible for breaking down and reabsorbing bone tissue during the natural remodeling process.

Examples of bone density conservation agents include:

1. Bisphosphonates (e.g., alendronate, risedronate, ibandronate, zoledronic acid) - These are the most commonly prescribed class of bone density conservation agents. They bind to hydroxyapatite crystals in bone tissue and inhibit osteoclast activity, thereby reducing bone resorption.
2. Denosumab (Prolia) - This is a monoclonal antibody that targets RANKL (Receptor Activator of Nuclear Factor-κB Ligand), a key signaling molecule involved in osteoclast differentiation and activation. By inhibiting RANKL, denosumab reduces osteoclast activity and bone resorption.
3. Selective estrogen receptor modulators (SERMs) (e.g., raloxifene) - These medications act as estrogen agonists or antagonists in different tissues. In bone tissue, SERMs mimic the bone-preserving effects of estrogen by inhibiting osteoclast activity and reducing bone resorption.
4. Hormone replacement therapy (HRT) - Estrogen hormone replacement therapy has been shown to preserve bone density in postmenopausal women; however, its use is limited due to increased risks of breast cancer, cardiovascular disease, and thromboembolic events.
5. Calcitonin - This hormone, secreted by the thyroid gland, inhibits osteoclast activity and reduces bone resorption. However, it has largely been replaced by other more effective bone density conservation agents.

These medications are often prescribed for individuals at high risk of fractures due to conditions such as osteoporosis or metabolic disorders that affect bone health. It is essential to follow the recommended dosage and administration guidelines to maximize their benefits while minimizing potential side effects. Regular monitoring of bone density, blood calcium levels, and other relevant parameters is also necessary during treatment with these medications.

Hydroxylysine is a modified form of the amino acid lysine, which is formed by the addition of a hydroxyl group (-OH) to the lysine molecule. This process is known as hydroxylation and is catalyzed by the enzyme lysyl hydroxylase.

In the human body, hydroxylysine is an important component of collagen, which is a protein that provides structure and strength to tissues such as skin, tendons, ligaments, and bones. Hydroxylysine helps to stabilize the triple-helix structure of collagen by forming cross-links between individual collagen molecules.

Abnormalities in hydroxylysine metabolism can lead to various connective tissue disorders, such as Ehlers-Danlos syndrome and osteogenesis imperfecta, which are characterized by joint hypermobility, skin fragility, and bone fractures.

Amelogenin is a protein that plays a crucial role in the formation and mineralization of enamel, which is the hard, calcified tissue that covers the outer surface of teeth. It is expressed during tooth development and is secreted by ameloblasts, the cells responsible for producing enamel.

Amelogenin makes up approximately 90% of the organic matrix of developing enamel and guides the growth and organization of hydroxyapatite crystals, which are the primary mineral component of enamel. The protein is subsequently degraded and removed as the enamel matures and becomes fully mineralized.

Mutations in the gene that encodes amelogenin (AMELX on the X chromosome) can lead to various inherited enamel defects, such as amelogenesis imperfecta, which is characterized by thin, soft, or poorly formed enamel. Additionally, because of its high expression in developing teeth and unique size and structure, amelogenin has been widely used as a marker in forensic dentistry for human identification and sex determination.

An allele is a variant form of a gene that is located at a specific position on a specific chromosome. Alleles are alternative forms of the same gene that arise by mutation and are found at the same locus or position on homologous chromosomes.

Each person typically inherits two copies of each gene, one from each parent. If the two alleles are identical, a person is said to be homozygous for that trait. If the alleles are different, the person is heterozygous.

For example, the ABO blood group system has three alleles, A, B, and O, which determine a person's blood type. If a person inherits two A alleles, they will have type A blood; if they inherit one A and one B allele, they will have type AB blood; if they inherit two B alleles, they will have type B blood; and if they inherit two O alleles, they will have type O blood.

Alleles can also influence traits such as eye color, hair color, height, and other physical characteristics. Some alleles are dominant, meaning that only one copy of the allele is needed to express the trait, while others are recessive, meaning that two copies of the allele are needed to express the trait.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Scoliosis is a medical condition characterized by an abnormal lateral curvature of the spine, which most often occurs in the thoracic or lumbar regions. The curvature can be "C" or "S" shaped and may also include rotation of the vertebrae. Mild scoliosis doesn't typically cause problems, but severe cases can interfere with breathing and other bodily functions.

The exact cause of most scoliosis is unknown, but it may be related to genetic factors. It often develops in the pre-teen or teenage years, particularly in girls, and is more commonly found in individuals with certain neuromuscular disorders such as cerebral palsy and muscular dystrophy.

Treatment for scoliosis depends on the severity of the curve, its location, and the age and expected growth of the individual. Mild cases may only require regular monitoring to ensure the curve doesn't worsen. More severe cases may require bracing or surgery to correct the curvature and prevent it from getting worse.

Alendronate is a medication that falls under the class of bisphosphonates. It is commonly used in the treatment and prevention of osteoporosis in postmenopausal women and men, as well as in the management of glucocorticoid-induced osteoporosis and Paget's disease of bone.

Alendronate works by inhibiting the activity of osteoclasts, which are cells responsible for breaking down and reabsorbing bone tissue. By reducing the activity of osteoclasts, alendronate helps to slow down bone loss and increase bone density, thereby reducing the risk of fractures.

The medication is available in several forms, including tablets and oral solutions, and is typically taken once a week for osteoporosis prevention and treatment. It is important to follow the dosing instructions carefully, as improper administration can reduce the drug's effectiveness or increase the risk of side effects. Common side effects of alendronate include gastrointestinal symptoms such as heartburn, stomach pain, and nausea.

Callosities are areas of thickened and hardened skin that develop as a result of repeated friction, pressure, or irritation. They typically appear on the hands and feet, particularly on the palms and soles, and can vary in size and shape. Callosities are not harmful but can cause discomfort or pain if they become too thick or develop cracks or sores. They are often seen in people who have jobs or hobbies that involve manual labor or frequent use of their hands, such as musicians, athletes, and construction workers.

HSP47 (Heat Shock Protein 47) is a type of molecular chaperone that assists in the proper folding and assembly of collagen molecules within the endoplasmic reticulum (ER) of eukaryotic cells. It is also known as SERPINH1, which stands for serine protease inhibitor, clade H (heat shock protein 47).

HSP47 binds to procollagen molecules in a highly specific manner and helps facilitate their correct folding and assembly into higher-order structures. Once the collagen molecules are properly assembled, HSP47 dissociates from them and allows for their transport out of the ER and further processing in the Golgi apparatus.

HSP47 is upregulated under conditions of cellular stress, such as heat shock or oxidative stress, which can lead to an accumulation of misfolded proteins within the ER. This upregulation helps to enhance the protein folding capacity of the ER and prevent the aggregation of misfolded proteins, thereby maintaining cellular homeostasis.

Defects in HSP47 function have been implicated in various connective tissue disorders, such as osteogenesis imperfecta and Ehlers-Danlos syndrome, which are characterized by abnormal collagen structure and function.

Dentin dysplasia is a rare genetic disorder that affects the development and formation of dentin, which is the hard tissue beneath the tooth's enamel. There are two types of dentin dysplasia: type I and type II.

Type I dentin dysplasia is also known as "radicular dentin dysplasia" and primarily affects the roots of the teeth. The roots may be short, thin, or even absent, which can make the teeth appear darkened or discolored. Despite the abnormal root structure, the teeth are often resistant to decay.

Type II dentin dysplasia is also known as "coronal dentin dysplasia" and primarily affects the crowns of the teeth. The teeth may appear normal in size and shape, but they can be prone to fractures and abscesses due to the thinness or absence of dentin beneath the tooth's enamel.

Both types of dentin dysplasia are inherited in an autosomal dominant manner, which means that a child has a 50% chance of inheriting the disorder if one parent is affected. Treatment for dentin dysplasia typically involves restorative dental procedures to address any tooth decay or fractures, and regular dental checkups to monitor the health of the teeth and gums.

"osteogenesis imperfecta". Merriam-Webster Dictionary. Retrieved 23 August 2021. Rowe DW (2008). "Osteogenesis imperfecta". ... Wikimedia Commons has media related to Osteogenesis imperfecta. "Osteogenesis Imperfecta Overview". NIH Osteoporosis and ... Shapiro JR (2014). "Clinical and Genetic Classification of Osteogenesis Imperfecta and Epidemiology". Osteogenesis Imperfecta. ... "Osteogenesis Imperfecta Surgical Management of the Femur and Knee" (ePub), Osteogenesis Imperfecta: A Case-Based Guide to ...
Osteogenesis imperfecta is a condition causing extremely fragile bones. ... Osteogenesis imperfecta is a condition causing extremely fragile bones. ... Osteogenesis imperfecta (OI) is present at birth. It is often caused by a defect in the gene that produces type I collagen, an ... Osteogenesis imperfecta. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of ...
In 1835, Lobstein coined the term osteogenesis imperfecta and was one of the first to correctly understand the etiology of the ... The earliest known case of osteogenesis imperfecta (OI) is in a partially mummified infants skeleton from ancient Egypt now ... encoded search term (Osteogenesis Imperfecta (OI)) and Osteogenesis Imperfecta (OI) What to Read Next on Medscape ... Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone. 2002 Jul. 31 (1):19-25. [QxMD MEDLINE Link]. ...
... Bone. 2021 Jun:147:115917. doi: 10.1016/j.bone. ... Introduction: Dental anomalies in Osteogenesis imperfecta (OI), such as tooth discoloration, pulp obliteration (calcified ...
Osteogenesis imperfecta. Disease definition A rare, genetic, primary bone dysplasias characterized by increased bone fragility ... Five clinically distinct types of osteogenesis imperfecta (OI) have been identified. The most clinically relevant ... Type I is mild and nondeforming with normal height or short stature, blue sclera, and no dentinogenesis imperfecta (DI). ...
... overview of osteogenesis imperfecta. Hospital for Special Surgery in NYC is nationally ranked #1 in orthopedics. ... Osteogenesis Imperfecta / Brittle Bone Disease. Osteogenesis imperfecta (OI) or "brittle bone disease" is a congenital disorder ... Wellness and osteogenesis imperfecta. *Wheelchair-Based Exercises for People with Osteogenesis Imperfecta ... In-Depth overview article on osteogenesis imperfecta. *Osteogenesis Imperfecta: A Multidisciplinary Approach to Treatment in ...
... "osteogenesis imperfecta tarda" sementara bentuk lebih teruk dianggap "osteogenesis imperfecta congenita."[15] Oleh kerana ini ... "Chicago Shriners Hospital - Osteogenesis imperfecta". Dicapai pada 2007-07-05.. *^ K. Buday, Beiträge zur Lehre von der ... Osteogenesis imperfecta (1895) *^ Sillence DO, Senn A, Danks DM (1979). "Genetic heterogeneity in osteogenesis imperfecta". J. ... 2000). "Type V osteogenesis imperfecta: a new form of brittle bone disease". J. Bone Miner. Res. 15 (9): 1650-8. doi:10.1359/ ...
... Nat ... Here we describe the initial results of allogeneic bone marrow transplantation in three children with osteogenesis imperfecta, ... indicating the feasibility of this strategy in the treatment of osteogenesis imperfecta and perhaps other mesenchymal stem cell ...
We offer support to those with Osteogenesis Imperfecta and their families. ... Paediatric Osteogenesis Imperfecta National Team . Find out more about services from the BBS Society. ... The Paediatric Osteogenesis Imperfecta National Team (POINT) was formed with an aim to provide a forum for clinicians in the UK ... Home Information Resources Healthcare and Treatments NHS OI Services Paediatric Osteogenesis Imperfecta National Team ...
Osteogenesis Imperfecta at MedExplorer. Reviewed health medical sites and medical information center. Including searchable ... Osteogenesis Imperfecta Foundation Osteogenesis imperfecta is a genetic disorder characterized by bones that break easily-- ... Osteogenesis Imperfecta Information , Add URL , Advertise , Employment , Conferences , Contact , , Mens Health , Womens ... Home : Disease Disorders : Osteogenesis Imperfecta [ Add URL to this Category ] Receding Hairline Treatment Read about the best ...
Osteogenesis Imperfecta (Brittle Bone Disease). Osteogenesis imperfecta, commonly known as brittle bone disease, is a lifelong ... While there is no cure for osteogenesis imperfecta, doctors manage the condition through intravenous medicine to strengthen the ... With osteogenesis imperfecta, the goal is to keep the child walking, to protect the bone from breaking all the time so that ... Without medical intervention, those with osteogenesis imperfecta could lose the ability to walk entirely. ...
Osteogenesis imperfecta. Lancet. 2004;363(9418):1377-85. *Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, et al. ... Osteogenesis imperfecta. Lancet. 2016;387(10028):1657-71. *Bonafe L, Cormier-Daire V, Hall C, Lachman R, Mortier G, Mundlos S, ... Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives *Aline Bregou Bourgeois ... Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr ...
The 26th OIFE AGM & celebration of our 25th anniversary took place in Dundee, Scotland from August 19th - 20th. The OIFE events were held after/in parallel with the 50th anniversary of the Brittle Bone Society (BBS), which took place from August 17th - 19th. The OIFE AGM took place from Sunday morning (Aug 19th) and there were 38 participants and 14 votes at most. In addition to usual AGM business, sharing of examples & ideas from the different organizations were in focus. As part of the OIFE AGM, the delegates participated in a joint session with the Brittle Bone Society, where the main topic was patient priorities in research. During the AGM we celebrated the OIFEs 25th anniversary with dinner, invited guests, speeches, anniversary cake and the launch of an anniversary video. ...
EURORDIS EuRR-Bone Mereo Biopharma OI-research OIF OIFE OIFE members OIFE Youth Event OI Foundation osteogenesis imperfecta ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Centers RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...
Osteogenesis imperfecta (OI) in Beagles. Osteogenesis imperfecta is an inherited connective tissue disease characterized by ... and severe osteogenesis imperfecta Journal of Bone & Mineral Research 16:1147-1153, 2001. Pubmed reference: 11393792. ...
Osteogenesis Imperfecta - Learn about the causes, symptoms, diagnosis & treatment from the MSD Manuals - Medical Consumer ... Symptoms of Osteogenesis Imperfecta Osteogenesis imperfecta can range from mild to severe. ... Osteogenesis imperfecta is an osteodysplasia. Osteodysplasias are disorders that disturb bone growth. Osteogenesis imperfecta ... Osteogenesis imperfecta causes the whites of the eyes (sclerae Structure and Function of the Eyes The structures and functions ...
Severe Osteogenesis imperfecta with oligodontia: think of MESD. Eur. J. Hum. Genet., 28 (SUPPL 1). S. 248 - 250. LONDON: ...
Osteogenesis imperfecta (OI) is a genetic bone disorder characterized by impaired production of type 1 collagen ... Learn and reinforce your understanding of Osteogenesis imperfecta. Check out our video library. ... Osteogenesis imperfecta (OI) is a genetic bone disorder characterized by impaired production of type 1 collagen, an essential ...
Pulmonary function and structure abnormalities in children and young adults with osteogenesis imperfecta point to intrinsic and ... Pulmonary function and structure abnormalities in children and young adults with osteogenesis imperfecta point to intrinsic and ... Pulmonary function and structure abnormalities in children and young adults with osteogenesis imperfecta point to intrinsic and ...
Context: Osteogenesis imperfecta (OI) is a bone fragility disorder associated with reduced muscle size, dynamic muscle function ... The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta.. Year: 2017 ... The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta. ...
Osteogenesis imperfecta, or brittle bone disease, is a genetic condition that causes frequent bone fractures and other ... Osteogenesis Imperfecta Foundation, About OI. Link. Osteogenesis Imperfecta Foundation, Fast Facts on Osteogenesis Imperfecta. ... Diagnosing Osteogenesis Imperfecta. In many cases, doctors can diagnose osteogenesis imperfecta before a baby is born. If a ... Treatment for Osteogenesis Imperfecta. There is no cure for osteogenesis imperfecta, but treatment can help people manage their ...
N2 - Osteogenesis imperfecta (OI) is a heterogeneous genetic disorder of bone and connective tissue, also known as brittle bone ... AB - Osteogenesis imperfecta (OI) is a heterogeneous genetic disorder of bone and connective tissue, also known as brittle bone ... Osteogenesis imperfecta (OI) is a heterogeneous genetic disorder of bone and connective tissue, also known as brittle bone ... abstract = "Osteogenesis imperfecta (OI) is a heterogeneous genetic disorder of bone and connective tissue, also known as ...
The European Commission support for the production of this publication does not constitute an endorsement of the contents which reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein ...
"Osteogenesis Imperfecta" by people in this website by year, and whether "Osteogenesis Imperfecta" was a major or minor topic of ... "Osteogenesis Imperfecta" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... Mobility in osteogenesis imperfecta: a multicenter North American study. Genet Med. 2019 10; 21(10):2311-2318. ... Rush ET, Li L, Goodwin JL, Kreikemeier RM, Craft M, Danford DA, Kutty S. Echocardiographic phenotype in osteogenesis imperfecta ...
In 1835, Lobstein coined the term osteogenesis imperfecta and was one of the first to correctly understand the etiology of the ... The earliest known case of osteogenesis imperfecta (OI) is in a partially mummified infants skeleton from ancient Egypt now ... encoded search term (Osteogenesis Imperfecta) and Osteogenesis Imperfecta What to Read Next on Medscape ... Living with ostogenesis imperfecta. The following tips have been developed by the Osteogenesis Imperfecta Foundation for taking ...
Abstract Osteogenesis imperfecta (OI) is a heritable disease of bone in which the hallmark is bone fragility. Usually, the ... 1 Sillence DO, Senn A, Danks DM 1979 Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16: 101-116. ... 25 Wallis GA, Sykes B, Byers PH, Mathew CG, Viljoen D, Beighton P 1993 Osteogenesis imperfecta type III: Mutations in the type ... 24 Aitchison K, Ogilvie D, Honeyman M, Thompson E, Sykes B 1988 Homozygous osteogenesis imperfecta unlinked to collagen I genes ...
Orange Socks is an initiative of RISE, Inc.,a 501(c)(3) organization. ...
To improve the quality of life of people living with OI in Ghana through education awareness creation, treatments and Mutual support. Read more. ...
Osteogenesis Imperfecta (OI) means imperfect bone formation, a term used to describe genetic disorders of the bone, causing ... Osteogenesis Imperfecta. Osteogenesis Imperfecta (OI) means imperfect bone formation, a term used to describe genetic disorders ... What Is Ostegenesis Imperfecta?. Osteogenesis imperfecta (OI), also known as brittle-bone disease, is a genetic (inherited) ... Clinics for Osteogenesis Imperfecta. * Orthopaedic Surgical Oncology Program 650-723-5643 * Osteoporosis and Metabolic Bone ...

No FAQ available that match "osteogenesis imperfecta"

No images available that match "osteogenesis imperfecta"